Correlation Between Anebulo Pharmaceuticals and Icosavax
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Icosavax, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Icosavax.
Diversification Opportunities for Anebulo Pharmaceuticals and Icosavax
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Anebulo and Icosavax is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Icosavax go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Icosavax
If you would invest 902.00 in Icosavax on November 3, 2024 and sell it today you would earn a total of 0.00 from holding Icosavax or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Anebulo Pharmaceuticals vs. Icosavax
Performance |
Timeline |
Anebulo Pharmaceuticals |
Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Anebulo Pharmaceuticals and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Anebulo Pharmaceuticals and Icosavax
The main advantage of trading using opposite Anebulo Pharmaceuticals and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |